ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
85,295
0,22%
Bitcoin
63 313,67
1,03%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Nautilus Biotechnology Inc (NAUT)

  7. Nautilus Biotechnology Inc (NAUT) Actualités

NAUT

Nautilus Biotechnology (NAUT)

Nautilus Biotechnology Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NAUT
DateHeureSourceTitreSymboleSociété
17/06/202423h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
13/06/202422h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAUTNautilus Biotechnology Inc
23/05/202414h00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
30/04/202414h00GlobeNewswire Inc.Nautilus Biotechnology Reports First Quarter 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/04/202414h00GlobeNewswire Inc.Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NAUTNautilus Biotechnology Inc
07/03/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NAUTNautilus Biotechnology Inc
06/03/202422h39Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NAUTNautilus Biotechnology Inc
28/02/202414h00GlobeNewswire Inc.Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202413h25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:NAUTNautilus Biotechnology Inc
28/02/202413h15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NAUTNautilus Biotechnology Inc
28/02/202413h04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NAUTNautilus Biotechnology Inc
22/02/202414h00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
07/02/202414h00GlobeNewswire Inc.Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:NAUTNautilus Biotechnology Inc
30/11/202314h00GlobeNewswire Inc.Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics AwardNASDAQ:NAUTNautilus Biotechnology Inc
01/11/202313h05GlobeNewswire Inc.Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell DevelopmentNASDAQ:NAUTNautilus Biotechnology Inc
31/10/202321h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAUTNautilus Biotechnology Inc
31/10/202313h05GlobeNewswire Inc.Nautilus Biotechnology Reports Third Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/10/202314h05GlobeNewswire Inc.Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023NASDAQ:NAUTNautilus Biotechnology Inc
06/09/202313h30GlobeNewswire Inc.Nautilus Biotechnology to Participate in Upcoming September Investor ConferencesNASDAQ:NAUTNautilus Biotechnology Inc
04/08/202314h00GlobeNewswire Inc.Nautilus Biotechnology to Participate in Upcoming August Investor ConferencesNASDAQ:NAUTNautilus Biotechnology Inc
02/08/202313h30GlobeNewswire Inc.Nautilus Biotechnology Reports Second Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
11/07/202315h23GlobeNewswire Inc.Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023NASDAQ:NAUTNautilus Biotechnology Inc
21/06/202312h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NAUTNautilus Biotechnology Inc
24/05/202314h05GlobeNewswire Inc.Nautilus Biotechnology to Participate in Upcoming June Investor ConferencesNASDAQ:NAUTNautilus Biotechnology Inc
02/05/202312h30GlobeNewswire Inc.Nautilus Biotechnology Reports First Quarter 2023 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
02/05/202312h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NAUTNautilus Biotechnology Inc
27/04/202322h09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NAUTNautilus Biotechnology Inc
27/04/202322h08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NAUTNautilus Biotechnology Inc
18/04/202322h05GlobeNewswire Inc.Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023NASDAQ:NAUTNautilus Biotechnology Inc
23/03/202313h00GlobeNewswire Inc.Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:NAUT

Dernières Valeurs Consultées

ASX
ORGKOF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés